Application of risk-adapted therapy for acute myeloid leukemia to a population. Effects of stem cell transplantation on outcome

被引：0
|
作者：
Wahlin, A
Brune, ML
Billstrom, R
机构：
[1] Univ Hosp, Umea, Sweden
[2] Sahlgrenska Univ Hosp, Gothenburg, Sweden
[3] Karnsjukhuset, Skovde, Sweden
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.4449.4449
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4449
引用
收藏
页码：195B / 195B
页数：1
相关论文
共 50 条
  • [1] Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach
    Lodewyck, Tom
    Cornelissen, Jan J.
    [J]. BLOOD REVIEWS, 2008, 22 (06) : 293 - 302
  • [2] Risk-adapted therapy of acute myeloid leukemia
    Hiddemann, W.
    Spiekermann, K.
    Braess, J.
    Feuring-Buske, M.
    Buske, C.
    Buechner, T.
    [J]. INTERNIST, 2006, 47 : S33 - S38
  • [3] Risk-adapted therapy in acute myeloid leukemia
    Fiegl, M.
    Hiddemann, W.
    [J]. INTERNIST, 2012, 53 (04): : 392 - +
  • [4] The Impact of Risk-Adapted Treatment Strategy on Outcome of Patients with Acute Myeloid Leukemia Aged ≥ 60 Years after Allogeneic Stem Cell Transplantation
    Sakr, Riwa
    Pilorge, Sylvain
    De Botton, Stephane
    Chahine, Claude
    Coman, Tereza
    Adler, Marcel
    Micol, Jean-Baptiste
    Pasquier, Florence
    Willekens, Christophe
    Danu, Alina
    Lazarovici, Julien
    Ghez, David
    Solary, Eric
    Ribbag, Vincent
    Bourhis, Jean-Henri
    Castilla-LLorente, Cristina
    [J]. BLOOD, 2017, 130
  • [5] The role of stem-cell transplantation in chronic lympocytic leukemia risk-adapted therapy
    Gine, Eva
    Moreno, Carol
    Esteve, Jordi
    Montserrat, Ernili
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (03) : 529 - 543
  • [6] Outcome of risk-adapted therapy for pediatric acute lymphoblastic leukemia in Egypt
    Sidhom, Iman A.
    Mokhles, Abir
    Soliman, Sonya
    Shaaban, Khaled
    Salem, Sherine
    Yassin, Dina
    Hassanein, Hala
    Hamdy, Nayera
    Rashed, Waffa
    El-Nashar, Amr
    Magdi, Hadeel
    Elhaddad, Alaa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Acute myeloid leukemia: from risk-adapted to genotype-specific therapy
    Kayser, S.
    Schlenk, R. F.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (31-32) : 1577 - 1580
  • [8] Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approach
    Mandelli, F
    Petti, MC
    Lo Coco, F
    [J]. HAEMATOLOGICA, 1998, 83 (11) : 1015 - 1023
  • [9] Risk-Adapted Maintenance Therapy for Acute Promyelocytic Leukemia
    Nagai, Sumimasa
    Takahashi, Tsuyoshi
    Kurokawa, Mineo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (02) : E21 - E21
  • [10] The Impact of Risk-adapted Treatment Strategy on Outcome of Patients with Acute Myeloid Leukemia Aged ≥ 60 Years after Allogeneic Stem Cell Transplant
    Sakr, Riwa
    Pilorge, Sylvain
    De Botton, Stephane
    Chahine, Claude
    Coman, Tereza
    Adler, Marcel
    Micol, Jean-Baptiste
    Pasquier, Florence
    Willekens, Christophe
    Danu, Alina
    Lazarovici, Julien
    Ghez, David
    Solary, Eric
    Ribrag, Vincent
    Bourhis, Jean-Henri
    Castilla-Llorente, Cristina
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S306 - S307
12345